CorFlow Therapeutics raised €2.2M in a funding round in Oct 2017. The company is based in Zug, Switzerland. Investors in the round: SEED+. Data as of 23 Sept 2026.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
This is the company's only recorded round.
